Development and evaluation of local regenerative biomimetic bone-extracellular matrix scaffold loaded with nano-formulated quercetin for orthopedic fractures
Source abstract
Abstract
The prevalence of bone injuries is greatly increasing each year and the proper healing of fractures without any complications is very challenging. Self-setting calcium phosphate cements (CPCs) have attracted great attention as bioactive synthetic bone substitutes. Quercetin (QT) is a multipurposed drug with reported bone-conserving properties. The loading of QT and QT-phospholipid complex within nanostructured lipid carriers (NLC) was proposed to overcome the poor physical properties of the drug and to introduce the use of bioactive excipients as phospholipids and olive oil. The aim of this work was to formulate a regenerative scaffold loaded with nano-formulated QT for local treatment of orthopedic fractures. For the first time, scaffolds composed of brushite CPC were prepared and loaded with quercetin lipid nano-systems. In vitro tests proved that the addition of lipid nano-systems did not deteriorate the properties of CPC where QT-NLC/CPC showed an adequate setting time, appropriate compressive strength, and porosity. The scanning electron microscope confirmed maintenance of nanoparticles integrity within the cement. Using a rat femur bone defect animal model, the histological results showed that the QT-NLC/CPC had a superior bone healing potential compared to crude unformulated QT/CPC. In conclusion, QT-NLC /CPC are promising lipid nano-composite materials that could enhance bone regeneration.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Calcium Carbonate Crystallization and Inhibition · Bone and Dental Protein Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (66)
Show source-provided references
1. The scope and sequence of growth factor delivery for vascularized bone tissue regeneration10.1016/j.jconrel.2015.08.004 ↗
2. Effects of estrogen on fracture healing in mice
3. Prevalence of pelvic fractures, associated injuries, and mortality: the United Kingdom perspective
4. The relative incidence of fracture non-union in the Scottish population (5.17 million): a 5-year epidemiological study10.1136/bmjopen-2012-002276 ↗
5. Review of bone graft and bone substitutes with an emphasis on fracture surgeries10.1186/s40824-019-0157-y ↗
6. Ionic modification of calcium phosphate cement viscosity. Part I: hypodermic injection and strength improvement of apatite cement10.1016/j.biomaterials.2003.08.066 ↗
7. Calcium orthophosphate cements for biomedical application10.1007/s10853-008-2527-z ↗
8. In vitro biodegradation of three brushite calcium phosphate cements by a macrophage cell-line10.1016/j.biomaterials.2006.04.030 ↗
9. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion10.1097/01.brs.0000201424.27509.72 ↗
10. Quercetin and vitamin C: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19). [Review]
11. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta10.1210/endo.139.10.6216 ↗
12. Quercetin as an agent for protecting the bone: a review of the current evidence10.3390/ijms21176448 ↗
13. Quercetin, a potent suppressor of NF-κB and smad activation in osteoblasts
14. The effect of quercetin delivery system on osteogenesis and angiogenesis under osteoporotic conditions10.1039/C6TB02312F ↗
15. Enhancement of quercetin oral bioavailability by self-nanoemulsifying drug delivery system and their quantification through ultra high performance liquid chromatography and mass spectrometry in cerebral ischemia10.1055/s-0043-109564 ↗
16. Improved oral absorption of quercetin from quercetin Phytosome®, a new delivery system based on food grade lecithin10.1007/s13318-018-0517-3 ↗
17. Nanostructured lipid matrices for improved microencapsulation of drugs10.1016/S0378-5173(02)00180-1 ↗
18. Effects of the olive tree leaf constituents on myocardial oxidative damage and atherosclerosis10.1055/s-0035-1546017 ↗
19. Major phenolic compounds in olive oil: metabolism and health effects10.1016/S0955-2863(02)00229-2 ↗
20. Changes in lipids during matrix: induced endochondral bone formation10.1007/BF02405092 ↗
21. Understanding the local actions of lipids in bone physiology10.1016/j.plipres.2015.06.002 ↗
22. A BMSCs-laden quercetin/duck's feet collagen/hydroxyapatite sponge for enhanced bone regeneration10.1002/jbm.a.36857 ↗
23. Quercetin inlaid silk fibroin/hydroxyapatite scaffold promotes enhanced osteogenesis10.1021/acsami.8b08119 ↗
24. Effect of direct loading of phytoestrogens into the calcium phosphate scaffold on osteoporotic bone tissue regeneration10.1039/C5TB01574J ↗
25. Maiti · 2005
26. Development of quercetin-phospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in SD rats10.1016/j.fitote.2016.07.008 ↗
27. Promoted antitumor activity of myricetin against lung carcinoma via nanoencapsulated phospholipid complex in respirable microparticles10.1007/s11095-020-02794-z ↗
28. Key production parameters for the development of solid lipid nanoparticles by high shear homogenization10.1080/10837450.2019.1647235 ↗
29. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability10.1016/j.ijpharm.2010.05.005 ↗
30. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles10.1016/j.jconrel.2008.10.002 ↗
31. Preparation and characterization of lipid based nanosystems for topical delivery of quercetin10.1016/j.ejps.2012.12.005 ↗
32. In vitro degradation and in vivo resorption of dicalcium phosphate cement based grafts10.1016/j.actbio.2015.08.031 ↗
33. Injectable β -TCP/MCPM cement associated with mesoporous silica for bone regeneration: characterization and toxicity evaluation10.1088/1748-605X/aa9085 ↗
34. Preparation of brushite cements with improved properties by adding graphene oxide10.2147/IJN.S196666 ↗
35. An evaluation of methods to determine the porosity of calcium phosphate cements10.1002/jbm.b.33173 ↗
36. Salvianolic acid B-loaded chitosan/hydroxyapatite scaffolds promotes the repair of segmental bone defect by angiogenesis and osteogenesis10.2147/IJN.S219105 ↗
37. High-strength resorbable brushite bone cement with controlled drug-releasing capabilities10.1016/j.actbio.2008.08.005 ↗
38. Spray-congealed solid lipid microparticles as a new tool for the controlled release of bisphosphonates from a calcium phosphate bone cement10.1016/j.ejpb.2017.10.002 ↗
39. Alendronate release from calcium phosphate cement for bone regeneration in osteoporotic conditions10.1038/s41598-018-33692-5 ↗
40. Measurement of total alkaline phosphatase activity in human serum10.1093/clinchem/21.13.1988 ↗
41. Levofloxacin and trovafloxacin inhibition of experimental fracture-healing10.1097/01.blo.0000087322.60612.14 ↗
42. Histological assessment of the effects of teriparatide therapy on mandibular fracture healing: a preclinical study10.1016/j.jcms.2020.01.006 ↗
43. Quercetin-phospholipid complex: an amorphous pharmaceutical system in herbal drug delivery10.2174/157016312799304507 ↗
44. Chapter 5 - lipid nanocarriers: preparation, characterization and absorption mechanism and applications to improve oral bioavailability of poorly water-soluble drugs
45. Systematic approach for the formulation and optimization of solid lipid nanoparticles of efavirenz by high pressure homogenization using design of experiments for brain targeting and enhanced bioavailability10.1155/2017/5984014 ↗
46. Oleuropein enhances osteoblastogenesis and inhibits adipogenesis: the effect on differentiation in stem cells derived from bone marrow10.1007/s00198-010-1270-x ↗
47. Formulation and evaluation of solid lipid nanoparticles of ramipril10.4103/0975-1483.83765 ↗
48. Vitamin D(3)-loaded nanostructured lipid carriers as a potential approach for fortifying food beverages; in vitro and in vivo evaluation10.15171/apb.2017.008 ↗
49. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions10.1016/S0378-5173(98)00092-1 ↗
50. Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects.[Review]
51. Comparing different sterol containing solid lipid nanoparticles for targeted delivery of quercetin in hepatocellular carcinoma10.3109/08982104.2013.868476 ↗
52. Naringenin-loaded dipalmitoylphosphatidylcholine phytosome dry powders for inhaled treatment of acute lung injury10.1089/jamp.2019.1569 ↗
53. Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers10.1016/j.colsurfb.2013.11.029 ↗
54. Quercetin-nanostructured lipid carriers: characteristics and anti-breast cancer activities in vitro10.1016/j.colsurfb.2013.08.032 ↗
55. Development and evaluation of chrysin-phospholipid complex loaded solid lipid nanoparticles - storage stability and in vitro anti-cancer activity10.1080/02652048.2018.1559369 ↗
56. Thermal reactions of brushite cements10.1002/jbm.b.30881 ↗
57. Calcium phosphate cements: action of setting regulators on the properties of the beta-tricalcium phosphate-monocalcium phosphate cements10.1016/0142-9612(89)90120-8 ↗
58. Magnesium calcium phosphate cement incorporating citrate for vascularized bone regeneration10.1021/acsbiomaterials.0c00929 ↗
59. Multiple characterization study on porosity and pore structure of calcium phosphate cements10.1016/j.actbio.2015.09.017 ↗
60. Synthesis of chitosan/brushite powders for bone cement composites10.2109/jcersj2.116.36 ↗
61. Morphological, spectroscopic and crystallographic studies of calcium phosphate bioceramic powders10.1007/s41779-017-0137-4 ↗
62. Differential response of human blood leukocytes to brushite, monetite, and calcium polyphosphate biomaterials10.1002/jbm.b.34385 ↗
63. Factors influencing the drug release from calcium phosphate cements
64. A statistical mechanical model for drug release: relations between release parameters and porosity10.1016/j.physa.2019.123165 ↗
65. Correlation of serum alkaline phosphatase activity with the healing process of long bone fractures in dogs10.1111/j.1939-165X.2005.tb00006.x ↗
66. Histomorphometric evaluation of bone healing in rabbit fibular osteotomy model without fixation10.1186/1749-799X-3-4 ↗